Ketamine Recruiting Phase 2 Trials for Major Depressive Disorder (MDD) Basic Science

IndicationsStatusPurposePhase
RecruitingBasic Science2
clinicaltrials.gov IdentifierTitleDrugs
NCT02418195miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome